New Metabolites of Methyldienolone by In Vitro Human Liver Microsomes and Characterized Using LC/HRMS for Doping Control Purposes

Documenti analoghi

• Characterization of Novel Metabolites of the HIF Stabilizer JNJ‐42041935 in Rats Using LC‐HRMS for Doping Control Purposes: A Pilot Study
  di: Jinghua Hou, et al.
  Pubblicazione: (2026)
• Metabolic Characterization of Vamorolone in Human Liver Microsomes: Implications for Anti‐Doping
  di: Zhongquan Li, et al.
  Pubblicazione: (2024)
• Biosynthesis and Identification of Clenbuterol Metabolites in Urine and In Vitro Microsome Incubation Samples Using UHPLC‐Q‐Exactive Orbitrap Mass Spectrometry: A Comparison Between Human and Bovine Metabolism
  di: Anuar Gómez‐Tagle, et al.
  Pubblicazione: (2025)
• Phase I Metabolism of Novel Phencyclidine Derivative 3‐Cl‐PCP: In Vitro Studies With Pooled Human Liver Microsomes and Investigation of a Post‐Mortem Case
  di: Johannes Kutzler, et al.
  Pubblicazione: (2026)
• Metabolism of Six Novel Nitazenes in Human Liver Microsomes Based on Ultra‐High‐Performance Liquid Chromatography Coupled With High‐Resolution Mass Spectrometry
  di: Bo‐yu Huang, et al.
  Pubblicazione: (2024)